Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 6,933.15
+97.45 (1.43%)
At close: Jul 13, 2026
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.81 trillion as of July 13, 2026. Its market cap has increased by 3.70% in one year.
Market Cap
1.81T
Enterprise Value
1.78T
Revenue
105.60B
Ranking
n/a
PE Ratio
70.67
Stock Price
6,933.15
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.81T, an increase of 89,053.96%. That is a compound annual growth rate of 33.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 1.81T | 6.94% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 250.40B |
| Shilpa Medicare | 122.62B |
| Suven Life Sciences | 94.46B |
| IOL Chemicals and Pharmaceuticals | 50.22B |
| Gujarat Themis Biosyn | 41.30B |
| Sai Parenteral's | 25.98B |
| NGL Fine-Chem | 19.70B |
| Bajaj HealthCare | 11.74B |